257 related articles for article (PubMed ID: 29316839)
1. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
[TBL] [Abstract][Full Text] [Related]
2. Development of an Inhibitor Screening Assay for Mono-ADP-Ribosyl Hydrolyzing Macrodomains Using AlphaScreen Technology.
Haikarainen T; Maksimainen MM; Obaji E; Lehtiö L
SLAS Discov; 2018 Mar; 23(3):255-263. PubMed ID: 29028410
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.
Bütepage M; Krieg S; Eckei L; Li J; Rossetti G; Verheugd P; Lüscher B
Methods Mol Biol; 2018; 1813():41-63. PubMed ID: 30097860
[TBL] [Abstract][Full Text] [Related]
4. PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation.
Torretta A; Chatzicharalampous C; Ebenwaldner C; Schüler H
J Biol Chem; 2023 Sep; 299(9):105096. PubMed ID: 37507011
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation.
O'Sullivan J; Tedim Ferreira M; Gagné JP; Sharma AK; Hendzel MJ; Masson JY; Poirier GG
Nat Commun; 2019 Mar; 10(1):1182. PubMed ID: 30862789
[TBL] [Abstract][Full Text] [Related]
6. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14.
Schuller M; Riedel K; Gibbs-Seymour I; Uth K; Sieg C; Gehring AP; Ahel I; Bracher F; Kessler BM; Elkins JM; Knapp S
ACS Chem Biol; 2017 Nov; 12(11):2866-2874. PubMed ID: 28991428
[TBL] [Abstract][Full Text] [Related]
8. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
[TBL] [Abstract][Full Text] [Related]
9. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
Daugherty MD; Young JM; Kerns JA; Malik HS
PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
[TBL] [Abstract][Full Text] [Related]
10. The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases.
Eckei L; Krieg S; Bütepage M; Lehmann A; Gross A; Lippok B; Grimm AR; Kümmerer BM; Rossetti G; Lüscher B; Verheugd P
Sci Rep; 2017 Feb; 7():41746. PubMed ID: 28150709
[TBL] [Abstract][Full Text] [Related]
11. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
[TBL] [Abstract][Full Text] [Related]
12. A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases.
Chen J; Lam AT; Zhang Y
Anal Biochem; 2018 Feb; 543():132-139. PubMed ID: 29247608
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2.
Moustakim M; Riedel K; Schuller M; Gehring AP; Monteiro OP; Martin SP; Fedorov O; Heer J; Dixon DJ; Elkins JM; Knapp S; Bracher F; Brennan PE
Bioorg Med Chem; 2018 Jul; 26(11):2965-2972. PubMed ID: 29567296
[TBL] [Abstract][Full Text] [Related]
14. Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs.
Maksimainen MM; Murthy S; Sowa ST; Galera-Prat A; Rolina E; Heiskanen JP; Lehtiö L
Bioorg Med Chem; 2021 Dec; 52():116511. PubMed ID: 34801828
[TBL] [Abstract][Full Text] [Related]
15. The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation.
Fu W; Yao H; Bütepage M; Zhao Q; Lüscher B; Li J
Drug Discov Today; 2021 Nov; 26(11):2547-2558. PubMed ID: 34023495
[TBL] [Abstract][Full Text] [Related]
16. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y
J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
Hopp AK; Hottiger MO
Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
[TBL] [Abstract][Full Text] [Related]
19. ENPP1 processes protein ADP-ribosylation in vitro.
Palazzo L; Daniels CM; Nettleship JE; Rahman N; McPherson RL; Ong SE; Kato K; Nureki O; Leung AK; Ahel I
FEBS J; 2016 Sep; 283(18):3371-88. PubMed ID: 27406238
[TBL] [Abstract][Full Text] [Related]
20. Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14).
Schweiker SS; Tauber AL; Sherry ME; Levonis SM
Mini Rev Med Chem; 2018; 18(19):1659-1669. PubMed ID: 30112992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
